Lifastuzumab (Anti-SLC34A2)
Lifastuzumab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. MW : 145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2350 |
| Sku # | A2350-1mg |
| Pricing | 1mg, $539.00 |